Vaccine and Infectious Disease Division
Opportunistic Infections in Cancer Patients
Many organisms that do not normally cause disease in immunocompetent persons can become life-threatening in those with compromised immune systems. Cancer patients undergoing immunosuppressive therapy and post transplant recipients are especially at risk for contracting one of these infections. Treatment and prevention, as well as molecular diagnostics, pathogenesis studies, and immunology are a few approaches implemented by VIDD faculty.
Infections in the immunocompromised host, especially diagnosis, prevention and treatment of CMV, VZV, BK virus, adenovirus, and respiratory virus infections. Research includes understanding the genetic basis of infeciton complications, genome and gene expression studies.
Phone: (206) 667-4898
Fax: (206) 667-4411
Epidemiology, natural history, and treatment of human herpesvirus 8 infection and treatment of Epstein Barr Virus-associated lymphomas. HIV-related cance and infections as a complication of cancer care. Cancer epidemiology, pathobiology, treatment and training in resource-limited settings.
Phone: (206) 667-4600
Fax: (206) 667-1965
Determining how changes in microbial communities impact human health; identifying, characterizing, and culturing microbes found in the human genital tract; and associating the reproductive tract microbiome with human disease.
Developing molecular diagnostic tests to detect and identify pathogens in immunocompromised hosts such as cancer patients.
Phone: (206) 667-1935
Fax: (206) 667-4411
Research interests include the study and manipulations of CD8 T cells and NK cells, the mechanism for T cells becoming memory T cells and the therapeutic potential of NK cells to protect from opportunistic infections following transplantation
Epidemiology, natural history, therapy, and prevention of HSV and other herpesvirus infections; interactions between HSV and HIV Vaccines and clinical trials
Phone: (206) 520-4340